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Tumor necrosis factor (TNF), a key effector in control-
ling tuberculosis, is thought to exert protection by
directing formation of granulomas, organized aggre-
gates of macrophages and other immune cells. Loss
of TNF signaling causes progression of tuberculosis
in humans, and the increased mortality of Mycobac-
terium tuberculosis-infected mice is associated
with disorganized necrotic granulomas, although
the precise roles of TNF signaling preceding this end-
point remain undefined. We monitored transparent
Mycobacterium marinum-infected zebrafish live to
conduct a stepwise dissection of how TNF signaling
operates in mycobacterial pathogenesis. We found
that loss of TNF signaling caused increasedmortality
even when only innate immunity was operant. In the
absence of TNF, intracellular bacterial growth and
granuloma formation were accelerated and was fol-
lowed by necrotic death of overladen macrophages
and granuloma breakdown. Thus, TNF is not required
for tuberculous granuloma formation, but maintains
granuloma integrity indirectly by restricting myco-
bacterial growth within macrophages and preventing
their necrosis.
INTRODUCTION
Pathogenic mycobacteria are highly adapted intracellular patho-
gens that can survive for indefinite periods of time within their
hosts. Infection results in the recruitment of host macrophages
to the bacteria, their phagocytosis, and the transit of infected
macrophages into deeper tissues (Cosma et al., 2003; Dannen-
berg, 1993). There the infected macrophages recruit additional
macrophages and other immune cells to form tightly aggregated
immune structures called granulomas, pathological hallmarks of
tuberculosis (Cosma et al., 2003; Dannenberg, 1993). In certain
host species, areas within tuberculous granulomas undergo
necrosis, referred to as caseation, so that mycobacteria may
occupy both an intracellular and extracellular niche during the
course of tuberculosis (Cosma et al., 2003).Tumor necrosis factor (TNF) is one of the first effector mole-
cules found to be essential in the host protective response
against tuberculosis (Flynn et al., 1995). Mice deficient either in
TNF or TNF receptor 1 have increased susceptibility to challenge
with pathogenic mycobacteria (Bean et al., 1999; Flynn et al.,
1995; Kaneko et al., 1999). The importance of TNF signaling in
protection against human tuberculosis has become especially
clear as a result of the increasing use of TNF-neutralizing drugs
in treating a variety of immune and inflammatory conditions
such as rheumatoid arthritis (Criscione and St Clair, 2002;
Keane, 2005). Patients receiving TNF-neutralizing therapy have
an increased rate of reactivation of latent tuberculosis (Gardam
et al., 2003). Similarly, TNF is required to prevent active disease
in mouse models of latent tuberculosis (Botha and Ryffel, 2003;
Chakravarty et al., 2008; Mohan et al., 2001), suggesting it is
required for the control of active as well as latent tuberculosis.
TNF can be produced by a variety of immune cells including
macrophages, neutrophils, and T cells (Vassalli, 1992) and has
pleiotropic effects in inflammation that affect cell activation
and migration, apoptosis, and other biological processes
(Locksley et al., 2001). Despite extensive investigation, the ef-
fects of the TNF pathway that play consequential roles in tuber-
culosis pathogenesis remain undefined. In vitro studies using
cultured macrophages have implicated TNF in distinct and con-
tradictory roles in mycobacterial pathogenesis, including induc-
tion of macrophage apoptosis that in turn leads to mycobacterial
death (Fratazzi et al., 1999), activation of macrophage antimicro-
bial effectors to reduce mycobacterial numbers (Appelberg
et al., 1994; Flesch and Kaufmann, 1990), or surprisingly, even
enhancing mycobacterial growth (Engele et al., 2002). However,
the in vivo studies that followed have led to the prevailing view
that TNF is responsible for granuloma formation and mainte-
nance, on the basis of the finding of disorganized granulomas
after infection of TNF-deficient mice (Algood et al., 2005; Bean
et al., 1999; Chakravarty et al., 2008; Flynn and Chan, 2001;
Kindler et al., 1989; Roach et al., 2002; Stenger, 2005). This hy-
pothesis is consistent with TNF’s well-known role in orchestrat-
ing macrophage trafficking and leukocyte movement during
inflammation (Kindler et al., 1989). The correlation of the protec-
tive role of TNF with the formation of granulomas, considered to
be host-protective structures, is also consistent with the concept
that tuberculous granulomas benefit the host by containing and
restricting mycobacteria (Flynn and Chan, 2001; Lawn et al.,
2002; Ulrichs and Kaufmann, 2006). This model is supported
by the concomitance of poorly formed granulomas and
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nocompromising conditions in humans and mice (Flynn and
Chan, 2001; Kaufmann, 2000; Lawn et al., 2002). More recently,
studies of Mycobacterium bovis, BCG infection in TNF- and
T cell-deficient mice suggested that at least in the context of
this attenuated strain, TNF exerts its effects primarily by damp-
ening overactive T cell responses and reducing granuloma and
lung-tissue destruction, rather than acting during the innate im-
mune phase of the response to mycobacterial infection (Zga-
niacz et al., 2004). Consistent with this anti-inflammatory role
ascribed to TNF, other studies have suggested that in tuberculo-
sis TNF deficiency mediates pathology and granuloma destruc-
tion that is independent of the increased bacterial numbers that
are also found (Ehlers et al., 1999; Smith et al., 2002).
The accessibility and optical transparency of the developing
zebrafish allows for a variety of unique experimental approaches
to study pathogenesis, including vital microscopy, whole-mount
in situ hybridization, and modified antisense oligonucleotides
(morpholinos) for functional gene knockdowns (Trede et al.,
2004). Zebrafish develop tuberculosis-like diseasewhen infected
withMycobacterium marinum, a natural pathogen of ectotherms
and the closest genetic relative of theMycobacterium tuberculo-
sis complex (http://www.sanger.ac.uk/Projects/M_marinum/)
(Stinear et al., 2008). The virulence factors tested to date suggest
thatM.marinumandM. tuberculosisshare virulencemechanisms
and effectors (Cosma et al., 2006; Stamm et al., 2003; Tobin and
Ramakrishnan, 2008; Volkman et al., 2004). Infection of adult ze-
brafish produces disease with hallmarks of active human tuber-
culosis, including caseation necrosis (Swaim et al., 2006). Adult
zebrafish have a complex adaptive immune system akin to that
of mammals (Traver et al., 2003), and infection with M. marinum
is moderated by adaptive immunity similar to the case withmam-
malian tuberculosis (Swaim et al., 2006). Advantageously, zebra-
fish can be infected and monitored during early development
when adaptive immunity has not yet developed (Trede et al.,
2004), allowing for the dissection of the contribution of innate
and adaptive immunity to infection (Clay et al., 2007; Davis
et al., 2002).M.marinum-infectedzebrafishembryosdevelopdis-
ease with essential features of adult tuberculosis, including gran-
uloma formation, showing that the early steps of mycobacterial
pathogenesis result from interactions ofmycobacteriawith the in-
nate immune system (Davis et al., 2002). Thismodel allows for the
sequential visualization of infection in single animals (Clay et al.,
2007;Cosmaet al., 2006;Davis et al., 2002; Volkman et al., 2004).
Using the zebrafish-M.marinummodel, we previously demon-
strated that TNF is induced in macrophages very early in infec-
tion and that innate macrophages can restrict mycobacterial
growth without input from the adaptive immune system (Clay
et al., 2007). Here, we used morpholinos to ablate TNF signaling
to reveal a substantial protective TNF effect that begins early and
in the sole context of innate immunity in mycobacterial infection.
We found that macrophage trafficking and granuloma formation
were not dependent on TNF signaling. Rather, the absence of
TNF signaling led to an increase in intracellular bacterial burdens
accompanied by accelerated granuloma formation and the ne-
crotic death of infected macrophages within well-formed granu-
lomas. Granuloma necrosis then rendered the bacteria extracel-
lular where their unrestricted growth continued to increase
bacterial burdens. Thus, TNF mediates its primary protective
284 Immunity 29, 283–294, August 15, 2008 ª2008 Elsevier Inc.effects in early infection by modulating bacterial growth and
macrophage death.
RESULTS
Knockdown of TNF Receptor 1 Increased Susceptibility
to M. marinum in the Context of Innate Immunity
The zebrafish genome encodes two putative TNF ligands with
Zfin database identification numbers ZDB-GENE-050317-1 and
ZDB-GENE-050601-2. Because of higher sequence homology
and the upregulation of the latter of these during infection with
M. marinum and other pathogens (Clay et al., 2007; Pressley
et al., 2005; Rojo et al., 2007), this gene has been identified as the
zebrafish TNF ortholog. Although fluorescent in situ hybridization
reveals TNF expression in macrophages (Clay et al., 2007),
infected Pu.1 morphant embryos lacking macrophages were
found to express TNF by endpoint reverse transcriptase PCR,
suggesting that other cell types also produce TNF in response
to M. marinum infection (data not shown).
Two splice-blocking morpholinos (Draper et al., 2001) were
designed against the TNF receptor 1 (TR1) ortholog (ZDB-
GENE-040426-2252) in order to completely abolish TNF signal-
ing, including any that may occur via the alternate TNF gene in
the zebrafish genome (see Figure S1 available online). Injection
of thesemorpholinos into fertilized eggs resulted in complete ab-
rogation of native TR1mRNA for 5 to 6 days postfertilization (dpf)
with partial blocking thereafter for at least 10 dpf (Figure S1 and
data not shown).
These TR1 morphant embryos survived similarly to control
embryos even when raised under conventional conditions in
the presence of their normal commensal flora (Figure 1A) and
appeared morphologically normal throughout the observation
period. The morphants cleared intravenously injected nonpatho-
genic Escherichia coli at rates similar to that of controls in a dose-
dependent fashion. Both control and TR1 morphant embryos
cleared one to ten CFU of E. coliwithin one day,50 CFU within
two days, and 100 CFU within three days of infection with no
mortality of the embryos (data not shown).
Upon intravenous M. marinum infection, TR1 morphants suc-
cumbed to infection significantly more quickly than their control
counterparts, reminiscent of the increased mortality of TNF-
deficient mice infected with M. tuberculosis (Figure 1A) (Flynn
et al., 1995). The TR1 morphants had a hazard ratio for death
of 5.7 over the 12 day observation period (p < 0.0001, Kaplan
Meier method with log-rank test) and a median time to death
of 9 days versus 12 days. Increased mortality of the embryos
was also associated with up to ten-fold greater bacterial burdens
in the TR1morphants as compared to control embryos in the first
six days (Figures 1B and 1C), comparable to the increased bac-
terial numbers seen in TNF-deficientmice early in infection (Flynn
et al., 1995; Stenger, 2005). These results show that TNF signal-
ing is important for the modulation of mycobacterial infection
from its early stages and does not require adaptive immunity
for protective effects in vivo.
TNFSignaling Is Not Required forMacrophageMigration
in Response to Infection
Having confirmed that TNF deficiency in zebrafish embryos
leads to the endpoint phenotypes of increased mortality and
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TNF Inhibits Mycobacterial Growth and Cell DeathFigure 1. TR1 Morphant Embryos Are More Susceptible to Mycobacterial Infection
(A) Control (Con) and TR1morphant embryos were either mock injected (n = 30 each) or infected with 108 ± 11 colony forming units (CFU) ofM.marinum on 1 dpf
(n = 50 each). Data are plotted as the percentage of surviving embryos on each day. TR1morphant embryos are significantly more susceptible to infection withM.
marinum than controls (Hazard ratio 5.7, p < 0.0001, Kaplan Meier method with log-rank [Mantel-Cox] test). Survival was not statistically different betweenmock-
injected TR1 and control embryos.
(B) Mean bacterial loads per embryo for control (Con), TR1, and Pu.1 morphant embryos at 2, 4, and 6 days post injection (dpi) with 70 ± 13 CFU. p < 0.0001 by
one-way ANOVA. Data for Pu.1 embryos are only available for 2 and 4 dpi because of mortality. Error bars represent standard deviation from the mean. All mor-
phant bacterial loads are significantly different from one another (p < 0.05) at each individual time points (control versus TR1, control versus Pu.1, and TR1 versus
Pu.1) by Student’s unpaired t test.
(C) Representative pictures of control, TR1, and Pu.1 morphant embryos at 4 dpi with fluorescence representing bacterial load. The scale bar represents 500 mm.bacterial growth seen in TNF deficiency in adult mammals, we
set out to determine the specific steps of mycobacterial patho-
genesis at which TNF acts by taking advantage of the transpar-
ency of the zebrafish. Because TNF signaling has been impli-
cated in macrophage activation and migration (Vassalli, 1992),
we first sought to determine whether mycobacteria could recruit
phagocytes across epithelial barriers in the absence of TNF
signaling by assessing macrophage recruitment to bacteria in-
troduced into the hindbrain ventricle (Davis et al., 2002; Herbo-
mel et al., 1999). The hindbrain ventricle is a neuroepithelial-lined
cavity that is structurally separated from the circulatory system
and the yolk mesenchyme in which macrophages arise during
early development; this cavity is normally devoid of macro-
phages in the first 24 hr after fertilization (Davis et al., 2002;
Herbomel et al., 2001). We had previously demonstrated that
phagocytes, readily identified by their morphology with differen-
tial interference contrast (DIC) microscopy, are specifically re-
cruited to this cavity upon injection of mycobacteria, but not
like-sized latex particles (Clay et al., 2007; Davis et al., 2002).
Similar numbers of phagocytes were recruited to the hindbrain
ventricle after injection of M. marinum into TR1 morphant and
control embryos (6 ± 1 macrophages in control and 6 ± 3 mac-
rophages in TR1 morphant embryos) (Figure S2). Macrophages
phagocytosed the bacteria and migrated back into tissues
normally in the TR1 morphants so that within 24 hr of hindbrain
ventricle or caudal vein injection, the majority of bacteria had
reached deeper tissues within macrophages (Figure 1C and
data not shown). These results suggest that TNF signaling is
not required for phagocyte trafficking across epithelial and en-
dothelial barriers; macrophages are competent to respond and
traffic to peripheral sites of infecting mycobacteria in the
absence of TNF signaling.Granuloma Formation Is Accelerated in the Absence
of TNF Signaling
The developing zebrafish is an ideal host in which to monitor
early granuloma formation because of our ability to follow in-
fected macrophages in individual animals over time (Davis
et al., 2002; Volkman et al., 2004). Infection of developing zebra-
fish leads to the formation of macrophage aggregates that are
easily identifiable by DIC microscopy and that have characteris-
tic pathological hallmarks of adult tuberculous granulomas, in-
cluding epithelioid transformation of macrophages (Davis et al.,
2002). In addition, several mycobacterial genes that are induced
in granulomas of adult animals (granuloma-activated genes
[gags]) are also induced rapidly and selectively upon macro-
phage aggregation into granulomas in the developing zebrafish
(Davis et al., 2002). Hereafter, we will refer to the early granulo-
mas in the developing zebrafish simply as granulomas.
In contrast with our expectation that TNF directs macrophage
trafficking into granulomas, DIC microscopy revealed an abun-
dance of granulomas inM.marinum-infected TR1morphant em-
bryos (Figures1Cand2A). To investigate this surprising result fur-
ther, we assayed granuloma formation by several methods. We
first used the fluorescence ofM. marinum-expressing transcrip-
tional fusions of GFP to gag7 (RecC) and gag3.13 (homolog of
M. tuberculosisRv0133, a putativeN-acetyltransferase) as sensi-
tive indicators of granuloma formation (Davis et al., 2002) in the
presence and absence of TNF signaling. Control and TR1 mor-
phant embryos were infected with gag7::gfp and gag3.13::gfp
M. marinum, and the percentage of embryos with fluorescent
bacteria was assessed after 4 days. A higher proportion of TR1
morphant embryos had formed gag-positive granulomas in com-
parison to control embryos at 4 dpi (Figures 2A and 2B) corrobo-
rating our impression from our initial qualitative DIC microscopy.
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TNF Inhibits Mycobacterial Growth and Cell DeathFigure 2. Granulomas Form More Quickly
in the Absence of TNF Signaling
(A) DIC (left) and fluorescence (right) images of
granuloma. Activated genes (gag3.13) in granulo-
mas in both control and morphant embryos are
shown as percentage of embryos with activation
of fluorescent reporters ± the standard deviation
of the mean. Scale bars represent 25 mm.
(B) Three pools of30 embryos were injected with
56 ± 18 CFU of gag7, and four pools of 30 em-
bryos were injected with 64 ± 17 CFU of
gag3.13. All groups were scored at 4 dpi for induc-
tion of gags as indicated by fluorescent activity.
The average percentage of embryos with gag
induction is plotted ± standard deviation of the
mean. Averages for both gag7 and gag3.13 are
significantly different between controls and mor-
phants (p < 0.05, Student’s unpaired t test).
(C–E) 23 Control and 14 TR1 morphant embryos
were injected with 89 ± 4 CFU and followed se-
quentially for 5 dpi and monitored for granuloma
formation and size. All dark bars represent control
morphant data; light bars represent TR1morphant
data. Data are plotted as average ± standard error
of the mean. (C) shows the percentage of embryos
with at least one granuloma over time. TR1 mor-
phant embryos have significantly more granulo-
mas at 3 dpi (p < 0.01) as analyzed by Fisher’s
exact test of a contingency table. (D) shows the
average number of granulomas identified by DIC
and fluorescent microscopy over time. (E) shows
that TR1 morphant granulomas are significantly
larger than control granulomas (p < 0.05 at 3 dpi,
p < 0.0001 at 4 and 5 dpi by Student’s unpaired t
test, n = 14; control and 14 TR1 granulomas at 3
dpi, 75 control and 53 TR1 granulomas at 4 dpi,
and 113 control and 72 granulomas at 5 dpi). The
y axis represents granuloma diameter in mm.
(F and G) Pools of 20 embryos were injected with
27 ± 6 wild-type (WT) and 51 ± 13 DRD1 M.
marinum and assayed by microscopy at 4 dpi for
granuloma formation. (F) shows representative images of control and TR1 morphant embryos. Arrowheads indicate granulomas. The scale bar represents
200 mm. As shown in (G), the average percentage of embryos with granulomas is plotted ± standard deviation of the mean over four biological replicates. The
percentage of embryos with granulomas is significantly higher when injected with WT (p < 0.01 for Con; WT versus Con; DRD1 and p < 0.001 for TR1; WT versus
TR1; DRD1 by Student’s unpaired t test).In order to better characterize the increase in granuloma
formation seen in the absence of TNF signaling, we monitored
granuloma formation and size over time by DIC and fluorescence
microscopy in control and TR1 morphant embryos. TR1 mor-
phant embryos formed granulomas more quickly than controls
(Figure 2C). At all time points, TR1morphants had more granulo-
mas than control embryos, although this difference was not sta-
tistically significant (Figure 2D). Moreover, the average size of
granulomas was significantly larger in TR1 morphant embryos
at all time points, suggesting a persistent acceleration in granu-
loma growth beyond the initial aggregation event (Figure 2E).
In the face of the widely held view that TNF signaling mediates
granuloma formation (Algood et al., 2005; Flynn and Chan, 2001;
Kindler et al., 1989; Lin et al., 2007; Roach et al., 2002), we
wanted to investigate further our finding that granuloma forma-
tion was not impaired but rather enhanced in the absence of
TNF. Although the simplest explanation of this finding is that
TNF does not mediate granuloma formation, we considered
the alternative possibility that TNF signaling does mediate gran-
286 Immunity 29, 283–294, August 15, 2008 ª2008 Elsevier Inc.uloma formation but that this phenotype is obscured by a distinct
mechanism of granuloma formation that becomes operant in its
absence. To investigate this question, we used the M. marinum
mutant that is deficient in the ESX-1 (RD1) secretion locus and
that produces infection with delayed and defective granulomas
(Volkman et al., 2004). We compared granuloma formation by
DIC and fluorescent microscopy, assaying for discrete foci of
tightly packed infected macrophage aggregates in control and
TR1 morphant embryos infected with wild-type (WT) and DRD1
bacteria at 4 dpi. The aggregation defect of DRD1 was main-
tained in the presence and absence of TNF signaling (Figures
2F and 2G). These data showed that granuloma formation pro-
ceeds via a mycobacterial RD1-dependent fashion regardless
of whether TNF signaling is present. Therefore, the abrogation
of TNF signaling does not uncover a distinct pathway of acceler-
ated granuloma formation. Rather, these findings suggest that
granulomas form in the course of normal infection by a pathway
that is independent of TNF signaling. In summary, these data
show that rather than preventing macrophage aggregation into
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kinetics of granuloma formation and expansion. Notably, despite
the absence of granuloma formation, we found some overall in-
crease in bacterial burdens in the TR1 morphants during DRD1
infection (data not shown), suggesting that TNF signaling exerts
its protective effect earlier than and independently of granuloma
formation. This finding is also consistent with previous studies
showing that TNF signaling exerts its protective effect in mice
infected with M. bovis BCG that lacks RD1 (Kindler et al., 1989;
Zganiacz et al., 2004).
TNF Signaling Exerts Protection In Vivo via Its
Macrophage Mycobactericidal Activity
We have previously demonstrated that macrophages restrict
mycobacterial growth from very early on during infection accom-
panied by TNF induction in infected macrophages (Clay et al.,
2007). The increased total bacterial burdens found in TR1
morphant embryos from very early in infection even prior to
granuloma formation further suggest that TNF signaling exerts
a protective effect in vivo bymediatingmacrophagemicrobicidal
activities (Figure 1B). This early increase in bacterial numbers in
individual macrophages could then lead to accelerated granu-
loma formation in TR1 morphant embryos. This model is sup-
ported by our finding that higher infecting inocula lead to more
rapid granuloma formation (data not shown).
We sought to determine whether TNF signaling mediated
macrophage microbicidal activities by enumerating the numbers
of bacteria in individual macrophages during infection (Cosma
et al., 2006). However, we were unable to make this determina-
tion with wild-type bacteria because even low-dose inocula in-
duced accelerated granuloma formation in the TR1 morphant
(Figure 2C), with selective recruitment of highly infected macro-
phages into granulomas in which they could not be scored, leav-
ing insufficient numbers of highly infected individually infected
macrophages available for analysis. To circumvent the rapid ki-
netics of granuloma formation with wild-type bacteria in the TR1
morphant, we took advantage of the attenuatedM. marinum Erp
mutant that is defective for growth in individual macrophages.
The intramacrophage growth defect of the Erp mutant is respon-
sible for its attenuation phenotype, which is rescued in Pu.1mor-
phant embryos lackingmacrophages (Clay et al., 2007). Second-
ary to its macrophage growth defect, the Erp mutant also has
reduced granuloma formation (data not shown). Therefore, we
reasoned that assessing the phenotype of the Erp mutant in
TR1 morphant embryos would isolate TNF-signaling-mediated
macrophage mycobactericidal effects from its other possible
protective effects on infection. First, we found overall increased
growth of the Erp mutant bacteria in the TR1 morphants as evi-
denced by increased bacterial burdens by fluorescence micro-
scopy (Figure 3A). Increased bacterial burdens were associated
with increased mortality of the TR1 morphant embryos as com-
pared to controls (mean time to death 9.6 versus 10.8 days, p <
0.01 by Student’s unpaired t test). Next, we scored the bacterial
burdens of individual infected macrophages in the embryos as
previously described (Cosma et al., 2006). As predicted, the
slower growth of the Erp mutant allowed for individual macro-
phage burdens to be assessed at a time point before all themac-
rophages had been recruited into granulomas, thereby allowing
for a higher number of infected macrophages to be scored forbacterial burdens; such scoring is not possible after macro-
phages are tightly aggregated. TR1 morphant embryos infected
with Erp mutant bacteria had a significantly higher percentage of
macrophages with high intracellular bacterial burdens (scored as
more than ten bacteria per macrophage versus low intracellular
bacterial burdens as ten or fewer bacteria per macrophage) (p <
0.05, Student’s unpaired t test) compared to control embryos
(Figures 3B–3D). These results suggest that TNF signaling exerts
a protective influence by restricting intracellular mycobacterial
growth in vivo. On the basis of our finding that wild-type bacterial
burdens in the TR1 morphants are significantly higher than in
controls, but not as high as those in the Pu.1 morphants (Figures
1B and 1C), we conclude that TNF signaling is upstream of part,
but not all, of macrophage effector mechanisms for combating
mycobacterial growth in individual macrophages by enabling
their microbicidal (or bacteriostatic) activity.
The effector molecule most widely ascribed to combating
mycobacterial growth in macrophages is the reactive intermedi-
ate nitric oxide, made by the inducible nitric oxide synthase
(iNOS) (Kwon, 1997). In order to determine whether iNOS is in-
duced during infection of zebrafish embryos with M. marinum,
we used fluorescent antibody detection of iNOS protein and co-
localized infected cells with iNOS antibody staining. Both control
and TR1 morphant embryos displayed iNOS staining that colo-
calized with a subset of infected macrophages (Figure S3). We
were unable to determine any differences in staining between
control and TR1morphant embryos, suggesting that TNF signal-
ing is not required for iNOS expression in our system, consistent
Figure 3. Growth of Erp Mutant Bacteria Is Partially Restored in TR1
Morphant Embryos
(A) Representative fluorescence images for control (Con) and TR1 morphant
fish infected with 55 ± 7CFU of Erpmutant (Erp)M.marinum at 4 dpi. The scale
bar represents 500 mm.
(B–D) A total of 50 individual macrophageswere scored for multiplicity of infec-
tion (MOI) as either containing (B) 10 or less bacteria or (C) more than 10 bac-
teria at 3 dpi during infection with 55 ± 7 CFU of Erp mutant bacteria. The scale
bar represents 25 mm. As shown in (D), the percentage of macrophages (out of
50) scored as either having more than ten, or ten or less bacteria per macro-
phage ± standard deviation of the mean in TR1 morphant versus control em-
bryos. TR1 morphants had a significantly greater percentage of macrophages
with more than ten bacteria as compared to controls (p < 0.05, Student’s
unpaired t test).
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TNF Inhibits Mycobacterial Growth and Cell DeathFigure 4. TR1 Morphant Embryos Have Significantly More Acellular Granulomas than Controls
(A and B) Differential interference contrast overlay with fluorescence (left) of infected embryos then labeled with in situ hybridization for the macrophage marker
fms (right). Green indicates M. marinum in fluorescent overlays. Purple staining of hybridized embryos indicates expression of the macrophage marker fms. (A)
shows an example of a cellular granuloma in a control embryo before and after in situ hybridization indicating bacteria within aggregatedmacrophages. (B) shows
an acellular granuloma example in a TR1 morphant embryo indicating bacteria found primarily outside of macrophages.
(C) The number of granulomas scored as either cellular or acellular in TR1 morphant versus control embryos. TR1 morphant granulomas were twice as likely to
contain one-third or fewer fms-positive cells than to WT granulomas (p < 0.0001) as analyzed by Fisher’s exact test of a contingency table. Embryos were 7 dpf
and infected with 267 ± 28 CFU.with previous reports in other systems (Bean et al., 1999; Bekker
et al., 2000; Ehlers et al., 1999).
Nonapoptotic Death of Granuloma Macrophages Is
Increased in the Absence of TNF
Our sequential imaging of live infected fish showed that although
granulomas formed rapidly and appeared normal at first in the
TR1 morphant embryos (Figure 2A), a combination of fluores-
cence and DIC microscopy revealed that they began to appear
larger and more acellular than control granulomas soon after
they had formed. To confirm this observation, we developed
a quantitative assay to assess the cellularity of granulomas in
control versus TR1 morphants using colorimetric whole-mount
in situ hybridization (WISH) analysis labeling the fmsgene, amac-
rophage-specific marker encoding the macrophage colony-
stimulating factor receptor (M-CSFR) (Clay and Ramakrishnan,
2005; Parichy et al., 2000). Only live macrophages will express
fms mRNA and therefore hybridize to the probe (Figures 4A
and 4B). WISH analysis was performed on control and TR1
morphant embryos 6 dpi. We scored granulomas by using a
blinded visual assay with DIC microscopy to identify bacterial
masses as being mostly cellular (greater than one-third of the
granulomamass hybridizing to the fmsprobe) (Figure 4A) or acel-
lular (one-third or less of the granuloma mass hybridizing to the
fms probe) (Figure 4B). Scoring of all of the individual granulomas
from the two groups showed that twice as many of the TR1 mor-
phant granulomas were acellular as compared to granulomas
from control embryos (Figure 4C). Although fms staining did
not appear different between uninfected TR1 and control mor-
phant embryos, there did appear to be an overall reduction in
fms-positive cells in infected TR1 morphants (data not shown),
suggesting that the accelerated macrophage death resulting
from the loss of TNF signaling leads to their overall depletion.
TNF has been shown tomodulate cell death in inflammation by
both pro- and antiapoptotic effects, and in vitro studies have
suggested that TNF mediates apoptosis of Mycobacterium-in-
288 Immunity 29, 283–294, August 15, 2008 ª2008 Elsevier Inc.fected macrophages that in turn results in death of the resident
bacteria (Fratazzi et al., 1999; Stenger, 2005). Because the TR1
morphants had increased cell death associated with exuberant
bacterial growth, we wondered whether it was due to a reduction
in apoptosis caused by the absence of TNF signaling that chan-
nels infected cells into a default pathway of necrotic death. Ne-
crosis of infected cells, in contrast to apoptotic death, is postu-
lated to allow the bacteria to survive (Fratazzi et al., 1999). We
have previously shown that some infected macrophages within
granulomas undergo apoptosis as indicated by the terminal de-
oxynucleotidyl transferase-mediated deoxyuridine triphosphate
nick end labeling (TUNEL) assay that labels double-strand DNA
breaks (Volkman et al., 2004). We found that several of these
TUNEL-positive macrophages express TNF as judged by dual
fluorescent labeling of whole embryos with in situ hybridization
for TNF expression and TUNEL labeling for apoptotic cells
(Clay and Ramakrishnan, 2005) (Figures 5A–5D). This finding
suggests that the TNF pathway could bemodulating the apopto-
sis that occurs in granuloma macrophages. However we found
no difference in the number of TUNEL-positive cells in like-sized
granulomas of control and TR1morphant embryos (Figure 5E). In
contrast, we found the expected reduction in TUNEL-positive
cells in granulomas that formed as a result of RD1-deficient
M. marinum (DRD1) infection (Figure 5E) (Volkman et al., 2004).
Next, we scored granulomas for either the presence or absence
of TUNEL-positive cells and compared TR1 morphant and con-
trol embryos for the percentage of total granulomas that had at
least one TUNEL-positive cell and again found no difference be-
tween the two groups (Figure 5F). With the recognition that some
forms of apoptosis do not lead to detectable double-stranded
DNA breaks (Huerta et al., 2007), these data suggest that TNF
signaling does not modulate apoptotic macrophage death within
granulomas. Furthermore, the increased cell death occurring in
the absence of TNF signaling as evidenced by the acellular gran-
ulomas is independent of changes in TUNEL-positive apoptotic
cell death.
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TNF Inhibits Mycobacterial Growth and Cell DeathFigure 5. TNF Signaling Does Not Influence the Rate of Apoptosis of Infected Cells
DIC and fluorescent imaging of a granuloma are shown in (A) and (B)–(D), respectively. (B) shows colocalization of TNF expression (red) and TUNEL-labeled dou-
ble-strand DNA breaks (green). Individual fluorescence channels for (C) TNF expression and (D) TUNEL-labeling are shown. The scale bar represents 50 mm. (E)
shows the number of TUNEL-positive cells per granuloma ± standard deviation of the mean. The average number of TUNEL-positive cells within granulomas in 4
dpi embryos is unchanged between control (n = 16 granulomas) and TR1 morphant embryos (n = 20). Infection of control embryos with RD1-deficient bacteria
(DRD1) is used as a control (n = 20). The number of TUNEL-positive cells inDRD1 granulomas is significantly less than control and TR1morphant granulomas with
wild-type bacteria (p < 0.05 by Student’s unpaired t test for both comparisons). Granulomas were selected to be between 40 and 50 mm in diameter to normalize
for total cell number. (F) shows the percentage of TUNEL-positive granulomas between control and TR1 morphant 4 dpi embryos ± standard error of the mean.
Three separate experiments of pools of 20–40 granulomas were scored per condition and plotted as number of granulomas with TUNEL-positive cells over total
granuloma number. Error bars represent standard error of the mean.Extracellular Corded Mycobacteria Accumulate in the
TR1 Morphants Leading to Accelerated Bacterial
Growth and Spread
On imaging live embryos, we had found that concomitant with
the loss of granuloma cellularity, the mycobacteria took on
a corded appearance. Cording morphology, in which the bacte-
ria are intertwined into serpentine rope-like structures (Koch,
1882), is a distinctive feature ofM. tuberculosis grown in culture
(Darzins and Fahr, 1956; Dubos and Pierce, 1956; Middlebrook
et al., 1947). In M. tuberculosis, genetic mutations that abolish
cording in vitro also result in reduced virulence (Bhatt et al.,
2007; Glickman et al., 2000). However, although cording
in vitro is tightly correlated to virulence, this phenotype has not
been observed in vivo previously. In this light, wewere first struck
by the appearance of corded bacteria in the Pu.1 morphants
(Clay et al., 2007) in which the bacteria are always extracellular
(Figure 6A). In contrast, bacteria within macrophages do not
exhibit this phenotype, suggesting that cording is a property of
extracellular bacteria regardless of whether they are in vitro or
in vivo (Figure 6B). Although not all extracellular bacteria demon-
strate a cording phenotype, it serves as a conservative estimate
of whether bacteria are growing extracellularly in vivo. We found
that the percentage of embryos with corded bacteria was signif-
icantly greater in TR1 morphants than in control embryos from
very early in infection (Figures 6C–6F). These results correlate
with our findings of increased macrophage death in the absence
of TNF signaling. Taken together, these data indicate that the ab-
sence of TNF signaling leads to increased macrophage death
and necrotic breakdown of granulomas with resultant exuberant
growth of extracellular mycobacteria. Notably, corded bacteria
were not always restricted to the acellular granulomas. Individual
clumps of corded bacteria were found that probably represent
those released from a single dead macrophage (Figure 6E).
This result suggests that TNF-pathway deficiency produces ac-
celerated death of both individual and granuloma macrophages
with release of extracellular bacteria.
To further dissect the pathway of the accelerated cell death
occurring in the absence of TNF, we again used theM. marinumESX-1(RD1) mutant. Infection of macrophages with the ESX-
1(RD1) virulence locus in vitro produces increased cell death
(Guinn et al., 2004; Hsu et al., 2003; Kaku et al., 2007). In the ze-
brafish, infection with DRD1 M. marinum results in fewer granu-
lomas that contain TUNEL-positive cells (Volkman et al., 2004).
In order to test whether bacterial RD1 is required for the in-
creased macrophage cell death seen in the absence of TNF sig-
naling, we infected control and TR1 morphant embryos with
DRD1 and looked for the presence of cording bacteria. Despite
the fact that DRD1M. marinum infection remains partially atten-
uated in TR1 morphant embryos presumably because of their
deficiency in forming granulomas (Figures 2F and 2G), infection
of thesemorphants with higher doses of this attenuated strain re-
vealed increased levels of cording bacteria in TR1morphant em-
bryos (Figure 7A). Consistent with the formation of poor granulo-
mas, the majority of corded bacterial masses were smaller than
those found during wild-type infection (compare Figures 7B and
7C to Figure 6D). This finding corroborated our observations with
wild-type bacteria that individual macrophages with accelerated
necrosis could be found outside of granulomas (Figure 6E). In
wild-type infection, the accelerated formation of granulomas
makes it more likely that macropahge necrosis occurs within
granulomas. However, it is clear from these experiments that
granuloma formation is not a prerequisite for macrophage necro-
sis. Taken together, these data indicate that increased cell death
resulting from the lack of TNF signaling is not dependent on the
DRD1 virulence locus or granuloma formation.
Additionally, time-lapse microscopy revealed several individ-
ual infected dead macrophages and even demonstrated that
a single dead macrophage may provide a means for dissemina-
tion of infection (Figure S4 and Movie S1). In this example, a sin-
gle infectedmacrophage in a TR1morphant embryo is phagocy-
tosed by two separate uninfected macrophages, indicating that
the death of single infected host cells is capable of spreading
bacteria to multiple uninfected macrophages. Thus, infected
macrophage cell death could accelerate infection both by giving
rise to extracellular bacteria as well as spreading infection to new
macrophages. The ability of bacteria to remain extracellular in
Immunity 29, 283–294, August 15, 2008 ª2008 Elsevier Inc. 289
Immunity
TNF Inhibits Mycobacterial Growth and Cell DeathFigure 6. TR1 Morphant Embryos Are More
Likely to Have Extracellular Bacteria as
Indicated by Cording
DIC (A) and fluorescence (B–E) imaging of bacteria
in vivo. As shown in (A) and (B), extracellular bac-
teria in Pu.1 morphant embryos without macro-
phages display the cording phenotype. The scale
bar represents 25 mm. As shown in (C) and (D), flat-
tened 3D Z stacks of control (C) and TR1morphant
(D) granulomas demonstrate cording in TR1 mor-
phant embryos. Scale bars represent 50 mm. (E)
shows cording after what appears to be break-
down of an individual infected macrophage in in-
fected TR1 morphant embryo. The scale bar rep-
resents 25 mm. As shown in (F), four pools of 30
embryos were injected with 18 ± 5 CFU and
scored daily for the presence of extracellular bacteria as indicated by cording and plotted as the percentage of embryos with cording ± the standard deviation.
TR1 morphant embryos had significantly higher percentages of embryos with cording at all time points by Student’s unpaired t test (p < 0.05 for 3 and 4 dpi,
p < 0.01 for 5 dpi).later stages of infection probably reflects a saturation effect in
which uninfected macrophages available for rephagocytosis of
extracellular bacteria are unable to keep up with the rate of
bacterial growth and infected macrophage death.
DISCUSSION
Our detailed stepwise dissection of the consequences of TNF re-
ceptor loss to mycobacterial pathogenesis shows that an accel-
erated increase in bacterial numbers occurs from the very early
stages of infection. Our prior work had demonstrated that innate
macrophages are capable of limiting mycobacterial growth to
a considerable extent and that TNF is induced in infected mac-
rophages within 24 hr after infection (Clay et al., 2007). The find-
ing that TR1 morphant embryos have an accelerated bacterial
burden during this early phase of infection suggests that the
TNF pathway plays a role in this early mycobacterial-growth re-
striction by macrophages. In support of this conclusion, we find
that the specific macrophage growth defect of a mycobacterial
mutant is partially rescued during infection of TNF-deficient em-
bryos. Our finding that TNF is protective in early tuberculosis
confirms experimental infection data in adult mammalian infec-
tion (Stenger, 2005) but is a formal demonstration that TNF sig-
naling can exert its protective effects in vivo in the absence of
adaptive immunity. By demonstrating that a key host protective
determinant can exert its effects in the context of innate immu-
nity alone, these results add to the growing appreciation for
a substantial role for innate immunity as an autonomous media-
tor of tuberculosis control aside from serving as the effector arm
of adaptive immunity (Berrington and Hawn, 2007; Clay et al.,
2007; Pan et al., 2005; Tosh et al., 2006; van Crevel et al., 2002).
Consistent with other experimental models of mycobacterial
infection, we find that loss of TNF signaling leads to an increase
in necrotic lesions and a loss of properly formed granulomas (Al-
good et al., 2005; Bean et al., 1999; Chakravarty et al., 2008;
Flynn et al., 1995; Kindler et al., 1989; Roach et al., 2002). Impor-
tantly, we demonstrate that granuloma breakdown can occur in-
dependently of T cell activity. The disorganized granulomas seen
in the absence of TNF signaling have been attributed to defects
in the primary formation of granulomas (Flynn and Chan, 2001;
Lin et al., 2007; Stenger, 2005). Our ability tomonitor the sequen-
290 Immunity 29, 283–294, August 15, 2008 ª2008 Elsevier Inc.tial steps of early infection has uncovered that the loss of TNF
signaling during M. marinum infection of zebrafish embryos
leads to altered kinetics of granuloma formation, with granulo-
mas forming more rapidly. This may be because TNF signaling
may impede granuloma initiation by restricting bacterial growth
early in infection. Conversely, TNF signaling deficiency causes
rapid and progressive disruption of granuloma structure be-
cause of increased granuloma expansion and the accelerated
necrosis of participating macrophages. Our data are consistent
with the previous finding that TNF-receptor-deficient mice in-
fected with M. tuberculosis formed granulomas in equal num-
bers to control mice when observed at early time points but
that only the TNF-deficient granulomas underwent subsequent
necrosis (Flynn et al., 1995). Other studies usingMycobacterium
avium have also noted that granulomas are formed but that they
rapidly disintegrate (Benini et al., 1999; Ehlers et al., 2000). Thus
the deficiencies in granuloma formation noted in many studies
Figure 7. Increased Cording Seen in the Absence of TNF Signaling Is
Not Dependent on the RD1 Virulence Locus or Granuloma Formation
(A) Control (n = 23) and TR1morphant (n = 9) embryos were infected with 353 ±
10DRD1 bacteria and scored daily for the presence of extracellular bacteria as
indicated by cording and plotted as the percentage of embryos with cording. A
significantly greater percentage of TR1 morphant embryos display cording
versus control embryos at 5 dpi (p < 0.01) and 6 dpi (p < 0.05) as analyzed
by Fisher’s exact test of a contingency table. (B) and (C) show examples of
cording found during infection of TR1 morphant embryos infected with
DRD1 at 6 dpi. The scale bar represents 25 mm.
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primary deficit in early granuloma formation (Bean et al., 1999;
Kindler et al., 1989; Roach et al., 2002). Alternatively, TNF may
have additional effects on granuloma structure in the context
of adaptive immunity by influencing processes such as T cell
trafficking and activation, and these changesmay independently
alter cell recruitment and structural organization in mature
granulomas. This possibility is supported by recent work demon-
strating that TNF is essential for recruiting T cells and retaining
uninfected, but not infected, macrophages within established
BCG-induced granulomas (Egen et al., 2008).
Our data suggest a model wherein TNF deficiency first leads
directly to impaired macrophage defenses that result in
increased intracellular bacterial burdens. The macrophage ef-
fector mechanisms downstream of TNF signaling responsible
for restricting mycobacterial growth are not well characterized.
iNOS activity confers resistance to mycobacterial infection in
mice (Adams et al., 1997), and TNF has been found to synergize
with IFN-g to activate macrophages to produce inducible nitric
oxide synthase iNOS, facilitating macrophage killing of intracel-
lularM. tuberculosis (Ding et al., 1988; Flesch et al., 1994). How-
ever, our results as well as previous reports (Bean et al., 1999;
Bekker et al., 2000; Ehlers et al., 1999) indicate that TNF signal-
ing mediates macrophage microbicidal activities in the context
of innate immunity that are probably not mediated by differences
in nitric oxide production resulting from iNOS activity. Other
known antimycobacterial mechanisms include phagolysosomal
fusion (Armstrong and Hart, 1971), vitamin D-mediated bacterial
killing (Liu et al., 2006) (Martineau et al., 2007), the production of
reactive oxygen intermediates (Adams et al., 1997), and produc-
tion and release of defensins (Miyakawa et al., 1996), small
antimicrobial peptides thought to be responsible for disrupting
bacterial cell-wall integrity (Menendez and Brett Finlay, 2007).
In addition to an increase in intracellular bacterial burdens in
the absence of TNF signaling, there is also an accelerated ne-
crotic death of infected macrophages both within and outside
of granulomas. This increased cell death may be secondary to
the accelerated increase in their bacterial burdens. The in-
creased size of granulomas that form without TNF signaling
suggests that increased bacterial burdens lead to increased
numbers of heavily infected macrophages and that this in-
creased bacterial burden ultimately leads to macrophage death
and depletion. Alternatively, it is possible that the loss of TNF
signaling initiates cell death via other mechanisms. The macro-
phage necrosis we observe may well result from the induction of
the lysosomal death pathway, a caspase-independent cell-
death pathway that resembles necrotic rather than apoptotic
cell death (Lee et al., 2006; O’Sullivan et al., 2007). This pathway
is induced by infection with M. tuberculosis only when bacterial
burdens within macrophages are high, thus providing a potential
link between the increased bacterial burdens and necrotic cell
death that we observe (Lee et al., 2006; O’Sullivan et al.,
2007). Although high intramacrophage bacterial burdens in the
absence of TNF signaling may be sufficient to induce the lyso-
somal death pathway, there are multiple places where TNF sig-
naling and its downstream effectors could potentially intersect
with and influence it (Broker et al., 2005; Liu et al., 2003).
Regardless of whether increased macrophage death is a pri-
mary or secondary effect of the loss of TNF signaling, it confersa further growth advantage to the bacteria by rendering them ex-
tracellular (Clay et al., 2007). Therefore in the absence of TNF sig-
naling, bacterial growth is enhanced at two stages: first within
macrophages whose microbicidal capacity is markedly but not
completely abolished and second by the death of the infected
macrophages that leads to a further enhancement in bacterial
replication by eliminating remaining macrophage defense mech-
anisms and mimicking the phenotype seen in Pu.1 morphant
embryos, in which bacterial growth in the extracellular milieu is
unrestricted (Clay et al., 2007). In addition, the observed acceler-
ation of granuloma formation and death of infected macro-
phages both have the potential to increase net bacterial burdens
by increasing cell-to-cell spread (Volkman et al., 2004) (Movie
S1). Therefore our work has isolated a primary role of TNF in re-
stricting bacteria within and to macrophages during early infec-
tion. The acceleratedmacrophage death that ensues further pro-
motes bacterial growth and could also independently influence
disease pathology at later stages by contributing directly to tis-
sue destruction as well as by disrupting chemokine gradients
and T cell activation, as noted during mycobacterial infection
of adult animals in the absence of TNF signaling (Algood et al.,
2005; Roach et al., 2002; Smith et al., 2002; Zganiacz et al.,
2004).
The importance ofmaintaining TNF signaling duringmycobac-
terial infection has been dramatically demonstrated by the use of
anti-TNF therapeutics during treatment of chronic autoimmune
disorders such as rheumatoid arthritis and Crohn’s disease,
which have demonstrated a particularly increased risk of tuber-
culosis (Gardam et al., 2003; Keane, 2005). Because of the kinet-
ics involved when patients develop symptoms of active tubercu-
losis, the use of anti-TNF therapeutics has been hypothesized to
result from reactivation of latent disease rather than an increased
susceptibility to primary infection (Gomez-Reino et al., 2007;
Keane, 2005). Notably, a number of clinical case studies of reac-
tivated tuberculosis under these conditions have reported dis-
crete well-formed granulomas in patient biopsies (Garcia Vidal
et al., 2005; Iliopoulos et al., 2006; Lange et al., 2007; Taylor
et al., 2003; Vlachaki et al., 2005; Wagner et al., 2002). Consis-
tent with our results that a loss of TNF signaling leads to
increased cell death, caseous necrosis was also found to be a
major histological feature of granulomas noted in these case
studies. Because the formation of caseum is a hallmark of active
disease, these results suggest that the primary role for TNF
signaling in human tuberculosis is also that of promoting macro-
phage survival. Our work has identified discrete steps of myco-
bacterial pathogenesis affected by this pleiotropic cytokine.
Countering the specific deficits that occur during TNF blockade
with downstream effectors has the potential to curtail the
incidence of tuberculosis that occurs during TNF blockade.
More importantly, a better understanding of TNF function may
lead to a better understanding of how to enhance host defenses
designed to control mycobacterial infection.
EXPERIMENTAL PROCEDURES
Animal Care and Strains
Wild-type WIK zebrafish embryos were maintained and infected with bacteria
as described (Cosma et al., 2006; Davis et al., 2002; Volkman et al., 2004). Sur-
vival curves were performed by separation of embryos into 15 mL plastic petri
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TNF Inhibits Mycobacterial Growth and Cell Deathdishes (10–15 embryos per dish) with half-water changes twice daily, with light
cycles and feeding with paramecia starting on 5 dpf.
Bacterial Strains
All bacterial strains are wild-type Mycobacterium marinum strain M unless
otherwise indicated. Fluorescent wild-type bacteria was used and prepared
as described (Davis et al., 2002). Erp mutant (Cosma et al., 2006) and DRD1
(Volkman et al., 2004) mutant strains were prepared as described.
Microscopy
Wide-field microscopy was performed on a Nikon E600 equipped with DIC
optics, a Nikon D-FL-E fluorescence unit with 100 W Mercury lamp and
MFC-1000 z-step controller (Applied Scientific Instrumentation). Objectives
used included 103 Plan Fluor, 0.3 NA, 203 Plan Fluor, 0.5 NA, 403 Plan Fluor,
0.75 NA, and 603 water Fluor, 1.0 NA. Wide-field fluorescence and DIC im-
ages were captured on a CoolSnap HQ CCD camera (Photometrics) with
MetaMorph 7.1 (Molecular Devices).
Three-Dimensional Image Processing
Where indicated, Z stacks were deconvolved with AutoDeblur Gold CWF, Ver-
sion X1.4.1 (Media Cybernetics), with default settings for blind deconvolution.
Bacterial CFU Enumeration
CFU counts were taken as described (Clay et al., 2007) with the following
changes: Embryoswere dissociated in 100 ml PBSby grindingwith amicrotube
pestles (USA Scientific). Because of the increased susceptibility of the Erpmu-
tant bacteria to the decontamination protocol used for plating fish lysates,
bacterial levels could only be examined by fluorescence microscopy; we
have previously demonstrated that bacterial levels correlate with bacterial
loads (Clay et al., 2007).
Morpholinos
Morpholinos were obtained from Genetools and injected at the one- to four-
cell stage. Control and Pu.1 morpholinos were used as described (Clay
et al., 2007). TNF receptor morpholinos were used as described (Bates
et al., 2007). Morpholino controls used were wild-type WIK embryos (experi-
ments for Figures 2B and 4 and Figure S1), Genetool’s control morpholino (ex-
periments for Figures 1,2A,3,5, and 6 and Figures S4 and S5), and the pbx mu-
tant morpholino (Hernandez et al., 2004) (experiments for Figures S2 and S3).
In Situ Hybridization
Fluorescent in situ hybridization and TUNEL labeling was performed as
described (Clay and Ramakrishnan, 2005), with fms probe and colorometric
detection as described (Parichy et al., 2000).
Antibody Staining
Antibody staining for iNOS was performed with TSA detection as described
(Clay and Ramakrishnan, 2005) with a rabbit polyclonal antibody (BD Biosci-
ences) shown previously to crossreact with zebrafish iNOS (Shin et al., 2000).
Statistics
Student’s unpaired t tests and contingency table analysis were performedwith
In-Stat software (Graphpad Software). Kaplan-meier analysis was performed
with Prism (Graphpad Software).
SUPPLEMENTAL DATA
Supplemental Data include four figures and one movie and can be found
with this article online at http://www.immunity.com/cgi/content/full/29/2/
283/DC1/.
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